REGN
$778.36 · +3.4% today · +4.9% 5d · +14.8% 3m · +40.3% 1y
Daily score63
Weekly score49
Long-term score84
Close
Scores (0–100)
Components — latest (2026-10-14)
Close
778.36
1D return
+3.4%
5D return
+4.9%
Rel volume
1.14
CMF 20
0.04
OBV slope 20
-0.16
Up-vol ratio 10
0.57
Short ratio
0.48
Short ratio Δ
−3.7%
Persistence 10
0.00
Inflow mean 5d
0.02
Inflow mean 60d
0.48
Momentum 12-1
+39.5%
% of 52w high
+91.4%
vs 200d
+6.1%
Volatility 60d
+31.4%
Dollar vol 20d
$609.18M
Insider buys 90d
$0
Insider buyers 90d
0.00
Revenue growth
+16.7%
Fundamentals — Regeneron Pharmaceuticals · Health Care
as of 2026-10-22- P/E
- —
- P/B
- —
- ROE
- 14.2%
- Operating margin
- 24.9%
- Debt / equity
- 0.06
- FCF yield
- —
- Years profitable
- 5/5
- BM score
- 62
- Moat flag
- No
Insider trades (Form 4)
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 24 | $758.16 | $18.2K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 35 | $755.91 | $26.5K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 16 | $757.68 | $12.1K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 14 | $759.96 | $10.6K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 219 | $764.40 | $167.4K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 25 | $763.76 | $19.1K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 55 | $762.57 | $41.9K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 27 | $761.36 | $20.6K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 74 | $760.65 | $56.3K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 271 | $765.39 | $207.4K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 279 | $766.47 | $213.8K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 192 | $767.39 | $147.3K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 105 | $768.33 | $80.7K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 127 | $769.30 | $97.7K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 12 | $770.20 | $9.2K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 283 | $771.56 | $218.4K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 211 | $772.56 | $163.0K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 224 | $773.40 | $173.2K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 121 | $774.48 | $93.7K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 376 | $775.46 | $291.6K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 66 | $776.31 | $51.2K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 38 | $777.76 | $29.6K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 454 | $778.64 | $353.5K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 380 | $779.59 | $296.2K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 463 | $780.63 | $361.4K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 50 | $781.47 | $39.1K |
| 2026-10-15 | MURPHY ANDREW J | Co-Chief Scientific Officer | Sell | 6 | $753.76 | $4.5K |
| 2026-09-03 | Guarini Kathryn | Director | Sell | 400 | $850.00 | $340.0K |
| 2026-09-03 | McCourt Marion | EVP Commercial | Sell | 1.1K | $857.39 | $969.7K |
| 2026-09-03 | McCourt Marion | EVP Commercial | Sell | 1.2K | $850.00 | $1.03M |
| 2026-08-12 | Guarini Kathryn | Director | Sell | 400 | $800.00 | $320.0K |
| 2026-08-12 | Zoghbi Huda Y | Director | Sell | 800 | $800.00 | $640.0K |
| 2026-07-07 | RYAN ARTHUR F | Director | Sell | 200 | $650.15 | $130.0K |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 14 | $705.56 | $9.9K |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 7 | $706.74 | $4.9K |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 6 | $709.45 | $4.3K |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 4 | $707.40 | $2.8K |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 2 | $714.13 | $1.4K |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 15 | $702.46 | $10.5K |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 5 | $701.76 | $3.5K |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 2 | $710.87 | $1.4K |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 5 | $711.49 | $3.6K |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 1 | $712.09 | $712 |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 15 | $704.28 | $10.6K |
| 2026-05-04 | RYAN ARTHUR F | Director | Sell | 24 | $703.46 | $16.9K |
Congress trades
| Filed | Traded | Member | Type | Owner | Amount | Lag | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-08 | 2026-05-15 | Gilbert Cisneros (CA31) | Sale | Self | $1,001 - $15,000 | 24 | |
| 2026-03-12 | 2026-02-12 | Julia Letlow (LA05) | Purchase | Self | $1,001 - $15,000 | 28 | |
| 2025-12-15 | 2025-11-18 | Gilbert Cisneros (CA31) | Purchase | Self | $1,001 - $15,000 | 27 |
Source: U.S. House Clerk periodic transaction reports (STOCK Act). Disclosures lag trades.